Read + Share
Wang K, Du R, Myall NJ, Lewis WE, et al. BRIEF REPORT: Real-world efficacy and safety of amivantamab for EGFR-mutant
non-small cell lung cancer (NSCLC). J Thorac Oncol 2023 Nov 25:S1556-0864(23)02376.
PMID: 38012986
|
 |
|
Wang K, Du R, Myall NJ, Lewis WE, et al. BRIEF REPORT: Real-world efficacy and safety of amivantamab for EGFR-mutant
non-small cell lung cancer (NSCLC). J Thorac Oncol 2023 Nov 25:S1556-0864(23)02376.
PMID: 38012986
|
|
|
|